. Moderna applies for U.S. authorization of its vaccine for use in adolescents. « JO LEE MAGAZINE

NY TIMES – Moderna requested an emergency authorization on Thursday from the Food and Drug Administration for use of its coronavirus vaccine in 12- to 17-year-olds. If authorized, as expected, the vaccine would offer a second option for protecting adolescents from the coronavirus, and hasten a return to normalcy for middle- and high-school students. The company has already filed for authorization with Health Canada and the European Medicines Agency, and plans to seek approval in other countries, the chief executive Stéphane Bancel said in a statement. Authorization by the F.D.A. typically takes three to four weeks.

More interesting news at NY TIMES

World on the Run | Jo Lee Magazine


Comments are closed.